Anticoagulation Practice Patterns in COVID-19: A Global Survey
The knowledge of the venous thromboembolic (VTE) complications associated with coronavirus disease 2019 (COVID-19) has evolved since the pandemic began. The survey below will discuss how your hospital is preventing VTE in patients with COVID-19 and if patients have experienced bleeding or thrombotic complications.
Although you will not get personal benefit from taking part in this survey, your responses will help inform the global community about current practice patterns. Of course, you have a choice about whether or not to complete the survey, but if you do participate, you are free to skip any questions or discontinue at any time.
Your response to the survey is anonymous which means no names will appear or be used on research documents or be used in presentations or publications. The research team will not know that any information you provided came from you.
The survey will take about 5-10 minutes to complete.
If you have any questions regarding the purpose of this study or the use of the data, you may contact the investigators at (email@example.com).
This survey has received exemption from ethics approval by MGH IRB (IRB protocol # 2021P001197). If you’d like to speak to someone not involved in this research about your rights as a research subject, or any concerns or complaints you may have about the research, contact the Mass General Brigham IRB at (857) 282-1900.
Please complete the survey below.